Literature DB >> 12729065

Biological variation of soluble CD163.

H J Møller1, P Hyltoft Petersen, L Rejnmark, S K Moestrup.   

Abstract

A soluble plasma form of CD163 (sCD163) was recently identified. The protein has anti-inflammatory effects in vitro and is elevated in patients with myelo-monocytic leukaemia and infection. For rational use and evaluation of this potential new quantity it is important to have knowledge of its biological variability and to use a methodology that has a sufficiently analytical quality. The day-to-day and diurnal biological variabilities of sCD163 were studied in 12 healthy people using a sandwich ELISA. The within-run-, between run- and total analytical coefficients of variation were estimated to 3.6%, 4.8% and 6.0%, respectively. The day-to-day within-subject biological variation was estimated to 9.0%, and the between-subject biological variation to 35.9%. A diurnal variation in sCD163 concentrations with 14% lower values in the night (supine position) was observed. The ratio between total analytical variation and within-subject biological variation was 0.67. The index of individuality, calculated as the ratio between within-subject biological variation and between-subject biological variation, was low and similar to complement factors and immunoglobulins. A low index of individuality is important in a monitoring situation where small changes from the set point of the individual can be detected in serial measurements. For this purpose, the critical difference for a series of results in the same patient (significant at p < 0.05) was calculated to 30% for samples taken on different days and measured in separate runs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729065     DOI: 10.1080/00365510310000439

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Soluble CD163: a biomarker linking macrophages and insulin resistance.

Authors:  T Parkner; L P Sørensen; A R Nielsen; C P Fischer; B M Bibby; S Nielsen; B K Pedersen; H J Møller
Journal:  Diabetologia       Date:  2012-03-27       Impact factor: 10.122

Review 2.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

3.  Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.

Authors:  Catherine Ingels; Holger J Møller; Troels K Hansen; Pieter J Wouters; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  J Clin Immunol       Date:  2012-11-13       Impact factor: 8.317

4.  Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy.

Authors:  Azza Gaber Antar Farag; Shymaa A El Askary; Waleed M Fathy; Fathia Elbassal; Ayman Ali Azzam; Nermin Reda Tayel; Samah Saad Abdul Karim; Wafaa Ahmed Shehata
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-06-02

5.  Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; David Gjertson; Timothy Ryner; Anthony W Butch
Journal:  BMC Immunol       Date:  2019-09-14       Impact factor: 3.594

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.